Live Broadcast on Metastatic Triple-Negative Breast Cancer


Join us for a live broadcast on Wednesday, June 17, 2020 at 5 PM PST and 8 PM PST.

Date/Times: Wednesday, June 17, 2020 at 5 PM PST and 8 PM PST

In this LIVE BROADCAST Dr. Hope S. Rugo will:

  • Review the clinical landscape of metastatic triple-negative breast cancer (TNBC)
  • Discuss appropriate populations for a new metastatic TNBC therapy
  • Assess recent data demonstrating the clinical efficacy and safety of a new therapy in patients with metastatic TNBC

Click here to register today!

Join This Multidisciplinary Expert:Hope S. Rugo, MD, Professor of Medicine; Director, Breast Oncology & Clinical Trials Education, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Sponsored By:

Related Videos
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD
Video 3 - "5-Year Data from the MonarchE Trial Investigating Abemaciclib in HR+, HER2- High-Risk, Early Breast Cancer"
Carlos Arteaga, MD
Video 2 - "NCCN Guidelines vs Real-World Practice: Risk Stratifying HR+/HER2- Early Breast Cancer"
Reshma L. Mahtani, DO